Analysis of peripheral blood mononuclear cells (PBMCs) from MS patients revealed a downregulated expression profile of PD-1 and PD-L1 mRNA that was substantially correlated with disease progression and the expanded disability status scale (EDSS) score. This evidence concerns the gene CD274 and myeloid sarcoma.